Nordic Pharma Lab ApS

CVR number: 39161672
Slotsmarken 12, 2970 Hørsholm

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales
External services-11.59
Gross profit-11.59-41.00- 106.00-24.00-18.79
Total depreciation- 178.00
EBIT-11.59-41.00- 284.00-24.00-18.79
Other financial expenses-0.08-9.00-10.25
Pre-tax profit-11.67-41.00- 284.00-33.00-29.04
Income taxes21.001.000.74
Net earnings-11.67-20.00- 283.00-33.00-28.30

Assets (kDKK)

20192020202120222023
Development expenditure91.00
Intangible rights88.00
Intangible assets total179.00
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables1.757.002.004.00
Current deferred tax assets22.00
Short term receivables total1.7529.002.004.00
Cash and bank deposits91.494.0027.004.004.19
Cash and cash equivalents91.494.0027.004.004.19
Balance sheet total (assets)93.24212.0029.008.004.19

Equity and liabilities (kDKK)

20192020202120222023
Share capital100.00100.00100.00100.00100.00
Other reserves71.00
Retained earnings-11.34-94.00-43.00- 326.00- 359.63
Profit of the financial year-11.67-20.00- 283.00-33.00-28.30
Shareholders equity total76.9957.00- 226.00- 259.00- 287.94
Provisions1.00
Non-current liabilities total
Current trade creditors28.0016.0019.0015.00
Current owed to group member110.00224.00248.00277.12
Other non-interest bearing current liabilities16.2516.0015.00
Current liabilities total16.25154.00255.00267.00292.12
Balance sheet total (liabilities)93.24212.0029.008.004.19
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.